Skip to content
To the full analysis

City Therapeutics Stock: Valuation and P/E

CTY
$18.35Closing price of 19 Nov 2026MEQIRI Score 58 out of 100

Here you can see what City Therapeutics Inc. costs today relative to earnings, sales and book value, and how that compares with its own valuation history. A high P/E is not a verdict by itself; what matters is whether it sits above or below what the market usually grants this company.

Daily figure as of 20 Nov 2026

P/E
no data
P/S
0.2
P/B
no data
PEG
no data

Against Its Own Valuation History

Each fiscal year is shown with its P/E on the year-end date, using the price at the time.

There is no reliable data on this for this company.

Data and Required Disclosures

  • ; time horizon around 12 months
  • Rated Neutral since 7 Nov 2026
  • Price: closing price of 19 Nov 2026
  • Data from Financial Modeling Prep (FMP) based on the company's reports, latest fiscal year 2019. MEQIRI calculates the score and fair value itself every night.
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.